HYTN Innovations Inc AI Stock Analysis
Want to see TSE:HYTN full AI Analyst Report?
HYTN Innovations Inc (HYTN) AI Stock Analysis
HYTN Innovations Inc
(CNQX:HYTN)
The score is held down primarily by weak financial performance (negative gross profit, large losses, ongoing cash burn, and negative equity). Technicals add further pressure with the stock trading below key moving averages and negative MACD. Valuation provides limited support because the negative P/E reflects unprofitability and there is no dividend yield data.
HYTN Innovations Inc (HYTN) vs. iShares MSCI Canada ETF (EWC)
- Market Cap
- CAD 11.51M
- Dividend Yield
- ―
- Average Volume (3M)
- 15.34K
- Price to Earnings (P/E)
- -6.4
- Beta (1Y)
- -1.16
- Revenue Growth
- 194.34%
- EPS Growth
- 75.23%
- Country
- Canada
- Employees
- 7
- Sector
- Consumer Defensive
- Sector Strength
- 62
- Industry
- Beverages - Non-Alcoholic
HYTN Innovations Inc Business Overview & Revenue Model
Company Description
HYTN Innovations Inc. is a Canadian firm engaged in the comprehensive development, manufacturing, marketing, distribution, and sale of cannabis products for the recreational adult-use market. The company's future product line is slated to include a d...
HYTN Innovations Inc Financial Statement Overview
Summary
Despite strong TTM revenue growth (~35% to ~$3.8M) and improving loss/cash-burn trends versus prior years, overall fundamentals remain high-risk: gross profit is slightly negative, operating and net margins are deeply negative (EBIT ~-35%, net ~-47%), operating/free cash flow are still negative (~-$0.6M each), and the balance sheet is stressed with negative shareholders’ equity (~-$1.46M) and ~$1.1M of debt.
Income Statement
18Very NegativeBalance Sheet
12Very NegativeCash Flow
15Very Negative| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Sep 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 3.77M | 1.67M | 851.49K | 763.46K | 696.36K | 0 |
| Gross Profit | -104.86K | 93.23K | 287.44K | 91.85K | 121.65K | 0 |
| EBITDA | -1.04M | -1.12M | -6.26M | -1.92M | -9.93M | -714.47K |
| Net Income | -1.77M | -1.52M | -6.61M | -2.33M | -17.38M | -959.48K |
Balance Sheet | ||||||
| Total Assets | 2.64M | 3.62M | 2.38M | 2.58M | 3.79M | 2.76M |
| Cash, Cash Equivalents and Short-Term Investments | 80.15K | 345.10K | 256.58K | 187.56K | 1.03M | 264.06K |
| Total Debt | 1.10M | 2.04M | 793.56K | 919.74K | 887.22K | 2.58M |
| Total Liabilities | 4.09M | 4.74M | 2.56M | 2.27M | 1.71M | 2.77M |
| Stockholders Equity | -1.46M | -1.12M | -172.97K | 314.72K | 2.07M | -8,879 |
Cash Flow | ||||||
| Free Cash Flow | -585.93K | -590.49K | -804.21K | -1.18M | -2.38M | -1.67M |
| Operating Cash Flow | -573.45K | -572.27K | -783.36K | -1.18M | -2.16M | -693.52K |
| Investing Cash Flow | -37.16K | -15.92K | 162.67K | -4,100 | 2.19M | -1.02M |
| Financing Cash Flow | 638.11K | 676.12K | 689.71K | 346.17K | 727.93K | 1.80M |
HYTN Innovations Inc Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:HYTN, the sentiment is Negative. The current price of 0.12 is below the 20-day moving average (MA) of 0.13, below the 50-day MA of 0.16, and below the 200-day MA of 0.19, indicating a bearish trend. The MACD of -0.01 indicates Positive momentum. The RSI at 44.48 is Neutral, neither overbought nor oversold. The STOCH value of 0.00 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for TSE:HYTN.
HYTN Innovations Inc Peers Comparison
Overall Rating
TSE:CGII43Neutral
TSE:HYTN42Neutral
Financial Indicators
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| TSE:HYTN | HYTN Innovations Inc | 0.12 | 0.00 | 0.00% | |
| TSE:CGII | Cleango Innovations Inc | 1.23 | 0.71 | 136.54% | |
| TSE:HYPE | Hemp for Health Inc | 0.15 | -0.13 | -44.64% | |
| TSE:MUSL | Element Nutritional Sciences Inc | 0.02 | -0.03 | -60.00% | |
| TSE:PTFY | Plantify Foods Inc | 0.09 | -0.29 | -76.84% |
HYTN Innovations Inc Corporate Events
HYTN to Spin Out Peptide Drug Unit into Peptide Development Labs
PositiveHYTN Innovations Inc., a pharmaceutical manufacturer of psychoactive and psychotropic products including cannabis-derived cannabinoids, serves federally regulated medical markets globally by deploying pharmaceutical-grade development and GMP manufact...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Oct 31, 2026
